Episode 26 - Patient-Focused Strategies to Effectively Diagnose, Treat, and Manage NF1-PN

This activity will provide a comprehensive overview of NF1-PN and will dive deeper into the nuances of treating and managing adult patients with inoperable symptomatic NF1-PN. Dr. Angela Hirbe will use clinical cases to illustrate best-practice approaches to optimally identify adult patients with NF1-PN that will benefit from approved MEK inhibitors and will detail how to choose between agents and address/prevent adverse effects. The work-up and monitoring recommendations will also be discussed and any insights for achieving improved outcomes among diverse patients will be detailed. This presentation will empower participants to make informed clinical decisions for different patients with distinct needs.Launch/Release Date: October 16, 2025Activity Expiration Date: September 30, 2026FACULTYAngela Hirbe, MD, PhDAssociate Professor of Medicine and Pediatrics DirectorAdult Neurofibromatosis Clinical Program Division of Oncology Sarcoma SectionWashington University School of MedicineSt. Louis, MissouriThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.